Description
1. Evidence in Pediatric Epilepsy Surgery 2. Ethical considerations in contemporary Pediatric Epilepsy Surgery 3. Controversies in timing of pediatric epilepsy surgery – is earlier better? Invasive Investigation 4. Electrocorticographic evaluation of epileptogenicity – Traditional vs novel biomarkers to guide surgery 5. Invasive Monitoring – stereoelectroencephalography (SEEG) vs. subdural electrode (SDE) evaluation vs hybrid evaluation Resective or ablative surgery 6. Intra-operative adjuncts to optimize the surgical treatment of drug-resistant epilepsy – Do new tools improve outcome? 7. medial Temporal lobe Epilepsy (TLE) – selective amygdalohippocampectomy (SAH) vs. anterior temporal lobectomy (ATL) 8. Epilepsy in eloquent cortex- Resection vs. responsive neurostimulation (RNS) 9. Lesional Epilepsy – Lesionectomy vs. ECoG-guided resection 10. Insular/peri-Sylvian Epilepsy – Resection vs. Stereotactic ablation (MR-guided laser ablation/Radiofrequency ablation) 11. Hypothalamic Hamartoma – Stereotactic radiosurgery (SRS) v. Stereotactic ablation (MR-guided laser ablation/Radiofrequency ablation) v. MRFUS 12. Tuberous Sclerosis Complex – Lesionectomy vs lesionectomy plus Disconnective Procedures 13. Functional hemispherotomy – Vertical vs. Lateral approach 14. Minimally Invasive Hemispherotomy – Endoscopic Assisted vs. Radiofrequency Disconnection 15. Lobar/Multi-lobar epilepsy – Resection vs. Disconnection 16. Lennox-Gastaut Syndrome – Callosotomy vs. Vagal nerve stimulation (VNS) 17. Corpus Callosotomy – Ant 2/3rd (2-stage) v. Complete (1-stage) Neuromodulation 18. TLE with preserved function: Multiple hippocampal transection (MHT) vs. Neuromodulation (DBS, RNS) 19. Neuromodulation – Neuromodulation vs ‘resective’, VNS vs. DBS (TSC, LGS, etc)
